We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,024.00
Bid: 11,500.00
Ask: 12,200.00
Change: 0.00 (0.00%)
Spread: 700.00 (6.087%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,024.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London midday: Bloomberg outage, Chinese regulations send stocks into the red

Fri, 17th Apr 2015 12:02

After a solid start UK stocks sank into the red by Friday lunchtime, moving further away from recent records amid a blackout on Bloomberg computer terminals and new regulations in China on short-selling.Bloomberg's trading and information units are heavily relied upon by roughly 320,000 people around the world and were thought to be affecting trading volumes.Meanwhile, China on Friday allowed fund managers to lend stocks for short-selling to boost the supply of shares."The news from China and the continued Bloomberg issues added to the already perilous situation in Greece to create an unfriendly trading environment at the end of the week," said Spreadex analyst Connor Campbell.The FTSE 100, which rose to a high of 7,093.52 early on, was down 0.65% at 7,014.37 by midday. The index had set a new all-time closing high on Wednesday at 7,096.78.All eyes continue to be on Greece as its debt crisis dominates proceedings at the International Monetary Fund-World Bank spring meetings in Washington.Pierre Moscovici, European Commissioner for economic and financial affairs, said there is no Plan B for Greece regarding a deal over a rescue package. Meanwhile, IMF managing director Christine Lagarde denied speculation that the IMF was willing to grant a delay on the repayment of loans due next month.Yanis Varoufakis responded by saying that Greece will "compromise, compromise, compromise without 'being' compromised".Data meets forecastsIn economic data on Friday, the UK unemployment rate fell from 5.7% to 5.6% in the three months to February, its lowest since July 2008 and in line with expectations. Weekly annual earnings growth picked up more than expected from 1.6% to 1.8%.The final estimate of the Eurozone consumer price index (CPI) confirmed that prices fell at a year-on-year rate of 0.1% in March, in line with initial readings but easing from a 0.3% drop in February.US inflation figures out later on are expected to show that prices stagnated again in March, with the CPI remaining at zero.Rolls-Royce and Astrazeneca riseEngine maker Rolls-Royce was among the best performers after winning its largest-ever order, worth $9.2bn, to provide Trent 900 engines and TotalCare service support to Emirates.Astrazeneca edged higher after its eye cancer treatment, selumetinib, was given 'orphan drug' status by US regulators, which should smooth its path to full approval.GKN was trading in the red after Exane BNP Paribas downgraded the stock to 'neutral'.Engineering and consulting outfit Ricardo was in demand after expanding its rail services with the £42.5m acquisition of consultancy and assurance business Lloyd's Register Rail.Shares in Applied Graphene Materials jumped after the graphene products group reported positive results from independent coatings trials.Market MoverstechMARK 3,205.44 -0.48%FTSE 100 7,014.37 -0.65%FTSE 250 17,602.55 -0.72%FTSE 100 - RisersSevern Trent (SVT) 2,144.00p +1.08%BP (BP.) 476.75p +0.70%Rolls-Royce Holdings (RR.) 984.50p +0.46%Pearson (PSON) 1,375.00p +0.36%Ashtead Group (AHT) 1,118.00p +0.27%Persimmon (PSN) 1,735.00p +0.12%Whitbread (WTB) 5,230.00p +0.10%Randgold Resources Ltd. (RRS) 5,085.00p +0.10%Sky (SKY) 1,048.00p +0.10%London Stock Exchange Group (LSE) 2,533.00p +0.08%FTSE 100 - FallersHikma Pharmaceuticals (HIK) 2,068.00p -2.73%St James's Place (STJ) 938.50p -2.09%Tesco (TSCO) 236.10p -2.05%GKN (GKN) 364.00p -1.78%Hargreaves Lansdown (HL.) 1,215.00p -1.78%Barclays (BARC) 255.95p -1.69%Schroders (SDR) 3,286.00p -1.68%Aberdeen Asset Management (ADN) 482.20p -1.59%3i Group (III) 497.90p -1.50%International Consolidated Airlines Group SA (CDI) (IAG) 563.50p -1.49%FTSE 250 - RisersHunting (HTG) 630.00p +4.74%QinetiQ Group (QQ.) 204.00p +4.56%Debenhams (DEB) 87.95p +3.59%Zoopla Property Group (WI) (ZPLA) 197.90p +2.06%Laird (LRD) 352.50p +1.73%Pennon Group (PNN) 849.50p +1.68%WH Smith (SMWH) 1,407.00p +1.59%Playtech (PTEC) 786.50p +1.22%Soco International (SIA) 184.70p +1.15%Countrywide (CWD) 532.00p +1.14%FTSE 250 - FallersEvraz (EVR) 196.10p -4.53%Rotork (ROR) 2,536.00p -4.05%Indivior (INDV) 206.10p -3.38%Ocado Group (OCDO) 354.00p -3.28%Henderson Group (HGG) 286.10p -3.18%Allied Minds (ALM) 676.50p -3.01%NMC Health (NMC) 704.50p -2.96%Supergroup (SGP) 958.00p -2.94%FirstGroup (FGP) 100.40p -2.52%Kaz Minerals (KAZ) 235.70p -2.48%
More News
13 Feb 2024 12:06

LONDON MARKET MIDDAY: Stocks fall but pound up before US data

(Alliance News) - Stock prices in London were on the decline on Tuesday afternoon, with sentiment tetchy ahead of a US inflation report later.

Read more
13 Feb 2024 09:32

LONDON BROKER RATINGS: Citi lifts GSK; Shore likes XPS Pensions

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
12 Feb 2024 12:04

LONDON MARKET MIDDAY: FTSE 100 underperforms as European peers rise

(Alliance News) - London's FTSE 100 underwhelmed on Monday, with some of its largest constituents pulling it lower, while indices in Europe were on the up on favourable comments on interest rate cuts by a European Central Bank official.

Read more
12 Feb 2024 09:41

LONDON BROKER RATINGS: Deutsche Bank starts Deliveroo at 'buy'

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
12 Feb 2024 09:12

Barclays sees "compelling" entry point at AstraZeneca after recent falls

(Sharecast News) - Barclays has kept an 'overweight' position on AstraZeneca despite the biopharma group's disappointing annual results last week, saying that the stock's recent underperformance provides an attractive entry point for investors.

Read more
9 Feb 2024 09:15

LONDON BROKER RATINGS: Deutsche Bank cuts AstraZeneca to 'sell'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
9 Feb 2024 07:51

LONDON BRIEFING: Barclays buys Tesco's retail banking business

(Alliance News) - Stocks in London are called to open higher on Friday, closing off a busy corporate week.

Read more
8 Feb 2024 17:00

LONDON MARKET CLOSE: Softer earnings weigh on underperforming FTSE 100

(Alliance News) - London's FTSE 100 ended lower on Thursday, with mixed corporate updates keeping a lid on enthusiasm, while in New York the S&P 500 has the 5,000 point mark in touching distance.

Read more
8 Feb 2024 14:42

London close: Stocks slip as US jobless claims fall

(Sharecast News) - London markets experienced a downturn in trading on Thursday, with stocks relinquishing earlier gains as investors processed a decrease in jobless claims in the United States.

Read more
8 Feb 2024 12:08

LONDON MARKET MIDDAY: DS Smith surges on takeover approach from Mondi

(Alliance News) - Stock prices in London were mixed at midday Thursday, as markets struggled to find direction amid a mixed wave of corporate updates and earnings.

Read more
8 Feb 2024 08:59

LONDON MARKET OPEN: Unilever up on buyback; BAT ups dividend

(Alliance News) - THE FTSE 100 in London opened slightly higher on Thursday, with earnings from British American Tobacco and Unilever boosting the index.

Read more
8 Feb 2024 08:44

TOP NEWS: AstraZeneca confident after 2023 profit more than doubles

(Alliance News) - AstraZeneca PLC on Thursday said it expects another year of strong growth after reporting pretax profit in 2023 more than doubled.

Read more
8 Feb 2024 07:58

AstraZeneca shares slip as Q4 profits miss forecasts

(Sharecast News) - Biopharma titan AstraZeneca delivered a 6% increase in sales in 2023 despite a $3.7bn decline in Covid-19 medicines revenues, as it guided to a strong pick-up in growth this year - though profits came in slightly under analysts' forecasts.

Read more
8 Feb 2024 07:50

LONDON BRIEFING: Unilever sets new buyback; Astra profit surges

(Alliance News) - Stocks in London are called to open slightly higher on Thursday, as investors eye a busy day of earnings.

Read more
2 Feb 2024 08:38

AstraZeneca celebrates latest successful trial of acoramidis in Japan

(Alliance News) - AstraZeneca PLC on Friday said positive results from a Phase 3 trial of acoramidis are consistent with global findings, bring the drug closer to regulatory submission in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.